SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-21-003083
Filing Date
2021-03-16
Accepted
2021-03-16 16:46:01
Documents
69
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K apre-20201231x10k.htm 10-K 2138469
2 EX-4.1 apre-20201231ex412221ad7.htm EX-4.1 17806
3 EX-21.1 apre-20201231ex211b87ffa.htm EX-21.1 6158
4 EX-23.1 apre-20201231ex23158b415.htm EX-23.1 5093
5 EX-23.2 apre-20201231ex2329f7f4f.htm EX-23.2 4035
6 EX-31.1 apre-20201231ex311b11371.htm EX-31.1 17960
7 EX-31.2 apre-20201231ex3128855dc.htm EX-31.2 16717
8 EX-32.1 apre-20201231ex321f11d16.htm EX-32.1 5311
9 EX-32.2 apre-20201231ex322f309b0.htm EX-32.2 5619
10 GRAPHIC apre-20201231x10k001.jpg GRAPHIC 53116
11 GRAPHIC apre-20201231x10k002.jpg GRAPHIC 14877
12 GRAPHIC apre-20201231x10k003.jpg GRAPHIC 23507
13 GRAPHIC apre-20201231x10k004.jpg GRAPHIC 26608
14 GRAPHIC apre-20201231x10k005.jpg GRAPHIC 20230
15 GRAPHIC apre-20201231x10k006.jpg GRAPHIC 21507
16 GRAPHIC apre-20201231x10k007.jpg GRAPHIC 17805
  Complete submission text file 0001558370-21-003083.txt   6193650

Data Files

Seq Description Document Type Size
17 EX-101.INS apre-20201231.xml EX-101.INS 1034635
18 EX-101.SCH apre-20201231.xsd EX-101.SCH 34470
19 EX-101.CAL apre-20201231_cal.xml EX-101.CAL 43377
20 EX-101.DEF apre-20201231_def.xml EX-101.DEF 132549
21 EX-101.LAB apre-20201231_lab.xml EX-101.LAB 359888
22 EX-101.PRE apre-20201231_pre.xml EX-101.PRE 257126
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39069 | Film No.: 21746500
SIC: 2834 Pharmaceutical Preparations